Dr Lal PathLabs Q4 Results: Net profit jumps 49% amid growing demand for diagnostic tests

Dr Lal PathLabs Q4 Results: New Delhi-headquartered Dr Lal PathLabs reported a 49 per cent year-on-year jump in consolidated net profit to Rs 84.5 crore for the March quarter. Its quarterly revenue grew 11.1 per cent to Rs 545.4 crore.

Dr Lal PathLabs Q4 Results: Net profit jumps 49% amid growing demand for diagnostic tests
Dr Lal PathLabs Q4 Results:

Dr Lal PathLabs Q4 Results: Diagnostics company Dr Lal PathLabs on Friday reported a consolidated net profit of Rs 84.5 crore for the January-March period, an increase of 49 per cent compared with the corresponding period a year ago. The opening of new labs and growing demand for medical tests boosted the company's profitability.  

The New Delhi-headquartered firm registered year-on-year growth of 11.1 per cent in revenue to Rs 545.4 crore for the quarter ended March 31, 2024, according to a regulatory filing.

Dr Lal PathLabs shares jumped after the earnings announcement, closing stranger by Rs 119.9, or 5.4 per cent, for the day at Rs 2,348.9 apiece on BSE. 

(This story will be updated shortly) 

Catch all the latest stock market updates here. For all other news related to business, politics, tech and auto, visit Zeebiz.com.

Get Latest Business News, Stock Market Updates and Videos; Check your tax outgo through Income Tax Calculator and save money through our Personal Finance coverage. Check Business Breaking News Live on Zee Business Twitter and Facebook. Subscribe on YouTube.

RECOMMENDED STORIES

https://www.zeebiz.com/market-news/news-short-term-investment-ideas-stocks-to-buy-for-15-days-axis-direct-recommends-fortis-healthcare-aegis-logistics-check-targets-334316

Looking for short term investment ideas? Analysts suggest buying these 2 stocks for potential gain; check targets

https://www.zeebiz.com/personal-finance/photo-gallery-power-of-compounding-how-soon-will-monthly-sip-of-rs-11000-reach-rs-8-crore-corpus-target-retirement-financial-planning-with-sip-calculator-334296

Power of Compounding: How soon will monthly SIP of Rs 11,000 reach Rs 8 crore corpus target?

https://www.zeebiz.com/personal-finance/photo-gallery-rs-3500-monthly-sip-for-35-years-vs-rs-35000-monthly-sip-for-16-years-which-can-give-you-higher-corpus-in-long-term-compound-interest-benefits-mutual-fund-return-calculator-retirement-planning-334249

Rs 3,500 Monthly SIP for 35 years vs Rs 35,000 Monthly SIP for 16 Years: Which can give you higher corpus in long term? See calculations

https://www.zeebiz.com/personal-finance/news-rs-1111-monthly-sip-for-40-yrs-11111-for-20-yrs-or-22222-for-10-years-which-works-best-at-same-expected-return-334395

Small SIP, Big Impact: Rs 1,111 monthly SIP for 40 years, Rs 11,111 for 20 years or Rs 22,222 for 10 years, which do you think works best?

https://www.zeebiz.com/personal-finance/photo-gallery-ppf-interest-rate-maturity-retirement-corpus-planning-calculator-how-to-get-inr-rs-72000-month-tax-free-income-from-public-provident-fund-calculations-80c-tax-benefits-333983

PPF Calculations: How to get Rs 72,000 a month tax-free income from Public Provident Fund?

Written By: ZeeBiz WebTeam
Updated: Fri, May 10, 2024
07:08 PM IST
New Delhi, ZeeBiz WebDesk
RELATED NEWS
Dr Lal PathLabs shares jump 8% post strong Q4 results; brokerages divided Dr Lal PathLabs shares jump 8% post strong Q4 results; brokerages divided
Dr Lal Pathlabs, Thyrocare, other diagnostic test stocks rise after Centre issues guidelines on JN.1 COVID-19 variant Dr Lal Pathlabs, Thyrocare, other diagnostic test stocks rise after Centre issues guidelines on JN.1 COVID-19 variant
Dr Lal PathLabs shares continue to rise for second straight day after medical diagnostics firm stages strong Q2 show Dr Lal PathLabs shares continue to rise for second straight day after medical diagnostics firm stages strong Q2 show

By accepting cookies, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts.

x